Abstract
The brain participates in the endocrine system through the hypothalamus, which contains the neurosecretory system that produces releasing hormones. Some of these hormones are secreted into the hypothalamohypophysial portal system to regulate anterior pituitary hormones, and others into the general circulation in the posterior pituitary to control water conservation and breast milk ejection. The hypothalamus and its connections with the anterior and posterior pituitary gland comprise the hypothalamic-pituitary unit [1, 2]. The hypothalamus regulates additional vegetative and autonomic functions, including eating, drinking, and temperature. Lesions in or around the hypothalamic-pituitary unit cause various clinical syndromes in the endocrine system associated with decreased or increased hormonal secretions. Tumors in or around the hypothalamus also produce other vegetative symptoms and involve other neural structures nearby; the optic nerves and chiasm are particularly vulnerable. At times, extension into the cavernous sinus causes eye movement difficulties. Obstruction of the third ventricle and its outflow occasionally results in hydrocephalus. Headache can be caused by traction on the pain-sensitive dura of the diaphragm of the sella.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Biller BMK, Daniels GH. Neuroendocrine regulation and diseases of the anterior pituitary and hypothalamus. In: Fauci AS, Braunwald E, Martin JB, editors. Harrison’s principles of internal medicine. 14th ed. New York: McGraw-Hill; 1998. p. 1972–99.
Reichlin S. Neuroendocrine control of pituitary function. In: Besser GM, Thorner MO, editors. Clinical endocrinology. London: Mosby-Wolfe; 1994. p. 12–6.
Melmed S, Jameson JL. Disorders of the anterior pituitary and hypothalamus. In: Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Localzo J, editors. Harrison’s principles of internal medicine. 18th ed. New York: McGraw-Hill; 2012. p. 2876–902.
Abrams GM, Zimmerman EA. Endocrine diseases. In: Rowland LP, editor. Merritt’s textbook of neurology. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 849–64.
Robertson GL. Disorders of the neurohypophysis. In: Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Localzo J, editors. Harrison’s principles of internal medicine. 18th ed. New York: McGraw-Hill; 2012. p. 2902–11.
Trainer PJ, Besser GM. Cushing’s syndrome. In: Besser GM, Thorner MO, editors. Clinical endocrinology. 2nd ed. London: Mosby-Wolfe; 1994. p. 8.2–8.10.
Sheehan JP, Xu Z, Salvetti DJ, Schmitt PJ, Vance ML. Results of gamma knife surgery for Cushing’s disease. J Neurosurg. 2013;119:1486–92.
Feelders RA, Hofland LJ. Medical treatment of Cushing’s disease. J Clin Endocrinol Metab. 2013;98:425–38.
Antunes JL, Zimmerman EA. The hypothalamic magnocellular system of the Rhesus monkey: an immunocytochemical study. J Comp Neurol. 1978;181:539–66.
Nauta WJH, Haymaker W. Hypothalamic nuclei and fiber connections. In: Haymaker W, Anderson E, WJH N, editors. The hypothalamus. Springfield: Charles C. Thomas; 1969. p. 136–209.
Laws ER, Vance ML, Hypophysitis JJAJ. Pituitary. 2006;9:331–3.
Guitelman M. Long-term follow-up of prolactinomas: should dopamine agonist treatment be life-long? Front Horm Res. 2006;35:88–101.
Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, et al. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab. 1985;60:698–705.
Frank G, Pasquini E, Farneti G, Mazzatenta D, Sciarretta V, Grasso V, Faustini Fustini M. The endoscopic versus the traditional approach in pituitary surgery. Neuroendocrinology. 2006;83:240–8.
Schwyzer L, Starke RM, Jane JA Jr, Oldfield EH. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly. J Neurosurg. 2015;122:798–802.
Suda K, Inoshita N, Iguchi G, Fukuoka H, Takahashi M, Nishizawa H, et al. Efficacy of combined octreotide and cabergoline treatment in patients with acromegaly: a retrospective clinical study and review of the literature. Endocr J. 2013;60:507–15.
Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355:2558–73.
Verbalis JG. Ten essential points about body water homeostasis. Horm Res. 2007;67:165–72.
Ziese R, van der Lube N, Hoorn EJ. Current and future options in SIADH. NDT Plus. 2009;2(suppl 3):iii2–iii10.
Ellison DH, Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356:2064–72.
De Martin M, Pecori Giraldi F, Cavagnini F. Cushing’s disease. Pituitary. 2006;9:279–87.
Tsagarakis S, Vassiliadi D, Kaskarelis IS, Komninos J, Souvatzoglou E, Thalassinos N. The application of the combined corticotropin-releasing hormone plus desmopressin stimulation during petrosal sinus sampling is both sensitive and specific in differentiating patients with Cushing’s disease from patients with the occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab. 2007;92:2080–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zimmerman, E.A. (2019). Neuroendocrine Disorders. In: Rosenberg, R. (eds) Atlas of Clinical Neurology. Springer, Cham. https://doi.org/10.1007/978-3-030-03283-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-03283-8_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-03281-4
Online ISBN: 978-3-030-03283-8
eBook Packages: MedicineMedicine (R0)